Please visit answersincme.com/HAJ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in oncology and oncology nursing discuss the clinical profiles of novel targeted therapies for triple negative breast cancer (TNBC) and multidisciplinary strategies for adverse event management to improve patient survivorship. Upon completion of this activity, participants should be better able to: Review the safety profiles of novel targeted treatment options for patients with pretreated advanced triple negative breast cancer (TNBC); Identify multidisciplinary, proactive, adverse event management strategies to enhance outcomes on novel targeted treatment options for pretreated advanced TNBC; and Outline patient-focused, multidisciplinary strategies that can enhance perception of care and on-treatment survivorship for advanced TNBC.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related